A

Alibaba Health Information Technology Ltd
HKEX:241

Watchlist Manager
Alibaba Health Information Technology Ltd
HKEX:241
Watchlist
Price: 3.51 HKD -1.13% Market Closed
Market Cap: 56.4B HKD
Have any thoughts about
Alibaba Health Information Technology Ltd?
Write Note

Net Margin
Alibaba Health Information Technology Ltd

4.3%
Current
2%
Average
1.6%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
4.3%
=
Net Income
1.2B
/
Revenue
28.3B

Net Margin Across Competitors

Country HK
Market Cap 56.4B HKD
Net Margin
4%
Country US
Market Cap 2.1T USD
Net Margin
8%
Country ZA
Market Cap 831B Zac
Net Margin
44%
Country CN
Market Cap 199.1B USD
Net Margin
9%
Country CN
Market Cap 139B USD
Net Margin
29%
Country CN
Market Cap 891.3B HKD
Net Margin
7%
Country UY
Market Cap 2.1T MXN
Net Margin
8%
Country AR
Market Cap 101.2B USD
Net Margin
8%
Country NL
Market Cap 93B EUR
Net Margin
121%
Country US
Market Cap 73.6B USD
Net Margin
-2%
Country CN
Market Cap 386.4B HKD
Net Margin
3%
No Stocks Found

Alibaba Health Information Technology Ltd
Glance View

Market Cap
56.4B HKD
Industry
Retail

Alibaba Health Information Technology Ltd. is a key player in the rapidly evolving landscape of digital healthcare in China, one of the world's largest markets for health services. This innovative subsidiary of Alibaba Group was founded in 2014, aiming to harness the power of advanced technology to enhance healthcare accessibility and efficiency. By leveraging big data, artificial intelligence, and cloud computing, Alibaba Health develops a comprehensive ecosystem that connects patients and healthcare providers seamlessly. Their platforms enable users to book appointments, purchase medications online, and access personalized health information, thereby improving overall health management for millions of individuals across China. As an investor, one cannot overlook Alibaba Health's strategic position in the booming digital healthcare sector fueled by an aging population and rising health awareness among Chinese consumers. The company has established significant partnerships with hospitals, pharmacies, and other healthcare stakeholders, facilitating integration across the health system. With its robust technological infrastructure and the backing of the Alibaba Group, Alibaba Health is well-equipped to capitalize on emerging trends and regulatory shifts in China's healthcare environment. Their ambitious growth strategy and commitment to innovation position them as a potential long-term investment, promising not only strong financial returns but also a meaningful impact on the lives of individuals seeking quality healthcare services.

Intrinsic Value
2.61 HKD
Overvaluation 26%
Intrinsic Value
Price
A

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
4.3%
=
Net Income
1.2B
/
Revenue
28.3B
What is the Net Margin of Alibaba Health Information Technology Ltd?

Based on Alibaba Health Information Technology Ltd's most recent financial statements, the company has Net Margin of 4.3%.